Cargando…
P320: A NOVEL MAMMALIAN L-ASPARAGINASE WITH NO L-GLUTAMINASE ACTIVITY IS HIGHLY EFFICACIOUS AGAINST T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA IN VIVO
Autores principales: | Van Trimpont, Maaike, Schalk, Amanda, Peeters, Evelien, Lammens, Tim, Goossens, Steven, Lavie, Arnon, Van Vlierberghe, Pieter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428352/ http://dx.doi.org/10.1097/01.HS9.0000968192.06349.52 |
Ejemplares similares
-
Novel Insights on the Use of L-Asparaginase as an Efficient and Safe Anti-Cancer Therapy
por: Van Trimpont, Maaike, et al.
Publicado: (2022) -
In vivo stabilization of a less toxic asparaginase variant leads to a durable antitumor response in acute leukemia
por: Van Trimpont, Maaike, et al.
Publicado: (2022) -
Structural and Kinetic Characterization of Guinea
Pig l-Asparaginase
Type III
por: Schalk, Amanda M., et al.
Publicado: (2014) -
Discovery of human-like L-asparaginases with potential clinical use by directed evolution
por: Rigouin, Coraline, et al.
Publicado: (2017) -
The potential of halophilic and halotolerant bacteria for the production of antineoplastic enzymes: L-asparaginase and L-glutaminase
por: Shirazian, Pejman, et al.
Publicado: (2016)